… well. Project Description: In the tissue samples obtained from APDC we will study to what extent Nurr1 and its target genes - those involved in DA synthesis and release and those involved in GDNF signaling - are affected in patients with PD or incidental LDB patients, compared to healthy age-matched controls. In addition we …

… appears to damage brain cells. Denali and other companies are working on LRRK2 inhibitors to counteract that … mutation," said Denali CEO Ryan Watts, PhD, in a press release. Results released last week from a Michael J. Fox … that population. "This initial discovery from genetics has opened up an entire new path forward for therapeutics, and …

… are diagnosed based on symptoms and clinical testing. However, these tests can be inaccurate, and … most of the alpha-synuclein found in the blood does not come from the brain. We propose to overcome this problem by … with PD or MSA (approximately 30 subjects per group). Now, we expand this investigation to two larger, …

… studies and being an active participant in the quest for a cure. No results were found for this topic. Please try another combination. Join the Study that's Changing Everything … It’s free, mailed to your home and takes just 15 minutes to complete. Get Your Test Today …

… will develop cognitive and motor test batteries that can be completed electronically during a routine clinical … interventions used in clinical trials can be expanded through more frequent assessments of cognitive and motor … and clinicians. The development and validation of an online method of assessment is particularly important for …

… infusion of an adeno-associated viral (AAV) vector containing the human aromatic l-amino acid decarboxylase … of a phase I safety trial. Here we report the findings for the first cohort of five patients. Methods: Patients … the AADC tracer, 6-[18F]fluoro-l-m-tyrosine (FMT), were performed at baseline and at 1 and 6 months after infusion as …